%D9%88%D8%B1%D9%85_%D8%AF%D8%A8%D9%82%D9%8A%E0%A6%97%E0%A7%8D%E0%A6%B2%E0%A6%BF%E0%A6%93%E0%A6%AE%E0%A6%BEGliomaCategory:GliomasGliomGliomGliomaGlioma%DA%AF%D9%84%DB%8C%D9%88%D9%85%D8%A7GlioomaGliomeGlioma%D7%92%D7%9C%D7%99%D7%95%D7%9E%D7%94GliomoGlioma%E7%A5%9E%E7%B5%8C%E8%86%A0%E8%85%AB%EA%B5%90%EC%A2%85_(%EC%9D%98%ED%95%99)GlioomGlejakGlioma%D0%93%D0%BB%D0%B8%D0%BE%D0%BC%D0%B0GliomaGliomGliom%D0%93%D0%BB%D1%96%D0%BE%D0%BC%D0%B0Q1365309%E7%A5%9E%E7%B6%93%E8%86%A0%E8%B3%AA%E7%98%A4
about
Tijn KolsterenNatural History of Patients With Brain and Spinal Cord TumorsTrial of Panobinostat in Children With Diffuse Intrinsic Pontine GliomaA Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasGenetic Analysis of Brain TumorsAwake vs. Asleep Craniotomy for Non-eloquent GliomasCytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients With Newly Diagnosed WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent MedulloblastomaA Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade GliomaChronic Convection Enhanced Delivery of TopotecanA Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Positron Emission Tomography-Computed Tomography (PET-CT) High-grade GliomaBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorAloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With BevacizumabA Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsRadiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCorrelation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With EpilepsyA Phase II Study to Treat Advanced Malignant GliomaLow-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)Gliogene: Brain Tumor Linkage StudySafety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaVEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaErlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaRitonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain TumorsDiffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed GlioblastomaSunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaImaging Malignant Glioma With 68Ga-DOTATOC PET/CTConvection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation TherapyFluorescence-guided Surgery for Low- and High-grade GliomasOvarian Aging in Low Grade Glioma (LGG) Treated With TemozolomideEmend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving TemozolomideEvaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation TherapyANG1005 in Patients With Recurrent High-Grade GliomaPhotodynamic Therapy (PDT) For Recurrent High Grade GliomasErlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
P1050
P1911
oligodendrogliomaastrocytomabrain gliomaspinal cord gliomathird ventricle chordoid gliomachordoid gliomacerebellar astrocytomadiencephalic astrocytomaspineal gland astrocytomaoptic nerve astrocytomamixed gliomaOligoastrocytomapilocytic astrocytomaBrainstem gliomaangiocentric gliomalow grade gliomagrade III gliomaoptic nerve gliomaVisual pathway glioma
P279
P509
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerNimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial originIDH1 and IDH2 mutations in gliomasCognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the ArtROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic StrategiesState of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literatureCD34 Over-Expression is Associated With Gliomas' Higher WHO GradePituicytoma Coexisting With Corticotroph Hyperplasia: Literature Review With One Case ReportAn Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant GliomaSmoking and Glioma Risk: Evidence From a Meta-Analysis of 25 Observational StudiesGlioma surgery in eloquent areas: can we preserve cognition?Association between Dietary Vitamin A Intake and the Risk of Glioma: Evidence from a Meta-analysisPerspectives in Intraoperative Diagnostics of Human GliomasManagement of Gliomas: Overview of the Latest Technological Advancements and Related Behavioral DrawbacksInverse Association between Prediagnostic IgE Levels and the Risk of Brain Tumors: A Systematic Review and Meta-AnalysisMolecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and TreatmentHeparin in malignant glioma: review of preclinical studies and clinical resultsAssociation between XRCC1 polymorphism 399 G->A and glioma among Caucasians: a systematic review and meta-analysis.The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyondAn Evidence-Based Review of Alternating Electric Fields Therapy for Malignant GliomasNew developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaClinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a reviewDo relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysisHistone H3 mutations--a special role for H3.3 in tumorigenesis?Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasionToxin-based targeted therapy for malignant brain tumorsMolecular biology of high-grade gliomas: what should the clinician know?Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsCognition and resective surgery for diffuse infiltrative glioma: an overviewFocal brainstem gliomas. Advances in intra-operative managementRecent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsIn-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for NeuroradiologistsTargeting immune checkpoints in malignant gliomaIDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literatureEvidence from a large-scale meta-analysis indicates eczema reduces the incidence of gliomaEvaluation of Mobile Phone and Cordless Phone Use and Glioma Risk Using the Bradford Hill Viewpoints from 1965 on Association or CausationStudy designs may influence results: the problems with questionnaire-based case-control studies on the epidemiology of glioma.Gliomatosis peritonei: a series of eight cases and review of the literature.Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic TargetsAssociation between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
P921
Q28370999-24B62F7D-6797-48B7-8F5A-0BC8017FC18BQ28370999-671C5BAA-8A73-4D51-B0F4-708CB16EB7B6Q28371000-3BE97E8D-48D5-4F24-B65E-A92167713CD2Q29938328-3AA876FA-65E3-4AE9-9C0D-E63AD347992AQ29938393-F911A982-0E4B-464B-B7AE-67743AA39B2BQ29938748-ED0359A1-6243-4006-9AA4-470774E37606Q32948491-1E50E527-DA08-41D9-92C0-5BADD572EE17
P2175
description
Nerbio-sistemako tumorea, glian jatorria duena
@eu
a type of tumor that starts in the brain or spine
@en
cáncer de tipo celular
@es
groupe de tumeurs de l’encéphale ou de la moelle épinière
@fr
nádorové onemocnění
@cs
tipo de tumor que começa no cérebro ou na espinha
@pt
tumori primari del sistema nervoso centrale
@it
tumoro en cerbo aŭ spino
@eo
type svulst med utgangspunkt i hjerne eller ryggmerg
@nn
von Gliazellen ausgehender Hirntumor
@de
name
Glejak
@pl
Gliom
@de
Gliom
@sr
Glioma
@gl
Gliomo
@io
Gliooma
@fi
gliom
@cs
gliom
@sv
glioma
@ca
glioma
@en
type
label
Glejak
@pl
Gliom
@de
Gliom
@sr
Glioma
@gl
Gliomo
@io
Gliooma
@fi
gliom
@cs
gliom
@sv
glioma
@ca
glioma
@en
altLabel
Glejaki
@pl
Glioma
@pl
Gliomas
@pt
Maligne glioom
@nl
glial cell tumor
@en
gliom
@nn
glioma maligno
@es
glioma, malignant
@en
glioma, malignant, no ICD-O subtype
@en
gliomas
@en
prefLabel
Glejak
@pl
Gliom
@de
Gliom
@sr
Glioma
@gl
Gliomo
@io
Gliooma
@fi
gliom
@cs
gliom
@sv
glioma
@ca
glioma
@en
P1995
P2293
P2888
P672
P2581
P486
P508
P646
P1193
P1296
P1417
science/glioma